HIV

The Pharmacy Times® human immunodeficiency virus (HIV) resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

What can we help you find?
London Mayor Calls for Broader Access to PrEP at Global HIV Conference
London Mayor Sadiq Khan has called for broader availability of pre-exposure prophylaxis drugs in his welcoming speech at the Fast-Track Cities 2019 conference, where leaders from 300 cities around the world will discuss municipal responses to HIV, tuberculosis, and viral hepatitis.
Long-Term Trends in HIV Mortality Show Prevalence of Underlying Infection
An autopsy-based study examined long-term trends in HIV-related mortality among individuals living with the disease in New York City.
Trending News Today: Investigational Long-Acting HIV Injection Shows Efficacy in Study
Top news of the day from across the health care landscape.
California Appropriations Committee to Discuss PrEP Bill
In recent months, legislation to increase access to pre- and post-exposure prophylaxis (PrEP and PEP) passed in California with a vote of 34-1 in the Senate and a unanimous vote in the Assembly. 
Study: Worse Cancer Outcomes in Older Patients with HIV Not Due to Treatment Differences
HIV-related immunosuppression may contribute to an elevated risk of cancer-related morbidity in elderly patients with the disease.
A New PrEP Drug Could Be On the Horizon
An FDA committee has recommended approval of Gilead’s Descovy to reduce the risk of sexually acquired HIV infection in those at high risk of acquiring the virus.
FDA Committee Recommends Approval of Descovy for HIV PrEP Indication
An FDA committee voted 16 to 2 to recommended emitricitabine 200 mg and tenofovir alafenamide 25 mg tablets (Descovy, Gilead) for a HIV pre-exposure prophylaxis indication.
Interventions Demonstrate Success for Increasing Viral Load Suppression in HIV
A study in the Bukoba municipality of Tanzania has suggested that scaling up HIV testing, improving linkages to HIV care, and strengthening retention of antiretroviral therapy interventions can help increase viral load suppression (VLS).
Study: PrEP Awareness and Use Is Increasing
Pre-exposure prophylaxis (PrEP) can reduce the risk of HIV infection in individuals at high risk.
Counseling Patients with HIV/AIDS
It is prudent for pharmacists to stay current with these therapies and prevention strategies, as they are well-positioned to educate and support patients in their illness.
CDC Study Demonstrates Need for More HIV Prevention Efforts Focusing on High-Risk Populations
A study by the CDC has made several findings around injection practices and sexual behaviors among HIV-positive persons who inject drugs.
HIV Vaccine Demonstrates Durability Against Hard-to-Fight Strains
Vaccine found to provide durable protection against the “death star” HIV strain, which is notably hard to fight.
+ Load More